SAFE-BioPharma Receives Safe Harbor Certification

SAFE-BioPharma Association has certified compliance with the US Department of Commerce and European Union Safe Harbor requirements for the protection of personal data. The non-profit association developed and manages the global SAFE-BioPharma® digital identity and signature standard, used within the biopharmaceutical and healthcare industries.

To qualify, SAFE-BioPharma developed its privacy policy to comply with the E.U.’s Safe Harbor Principles. Safe Harbor Certification will enable SAFE-BioPharma to transfer personal data outside the E.U., expediting the flow of information between European clients and the United States. The certification recognizes that SAFE-BioPharma’s privacy and data security policies provide "adequate protection" for personal data from its European clients as required by the European Union's Data Protection Directive.

“Receiving Safe Harbor status assures SAFE-BioPharma member companies that use of the standard to manage digital identities and/or to apply digital signatures is consistent with E.U. regulations regarding data transfer and will further enhance our capabilities to better serve our European clients,” said Mollie Shields-Uehling, President and CEO, SAFE-BioPharma Association.

Details regarding E.U. Safe Harbor Principles are available at http://www.safe-biopharma.org/infocenter/SafeHarborOverview.pdf.

About SAFE-BioPharma Association (www.safe-biopharma.org) SAFE-BioPharma Association is the non-profit association that created and manages the SAFE-BioPharma® digital identity and signature standard for the pharmaceutical and healthcare industries.

The SAFE-BioPharma industry standard is used to mitigate legal, regulatory and other business risk associated with business-to-business and business-to-regulator electronic transactions. It facilitates interoperability by providing a secure, enforceable, and regulatory-compliant way to verify identities of parties involved in electronic transactions. Because the standard is linked to the Federal Bridge PKI Architecture through the 4BF (http://www.the4bf.com), a SAFE-BioPharma digital identity can be trusted by any Federal agency. SAFE-BioPharma’s vision is to be a catalyst in transforming the biopharmaceutical and healthcare communities to a fully electronic business environment by 2012.

The Association’s members include:

SAFE-BioPharma® is a trademark of SAFE-BioPharma Association. Any use of this trademark requires approval from SAFE-BioPharma Association.

Contacts:

SAFE-BioPharma Association
Jon Weisberg
M 801-860-9977
O 801-359-9977
Jon.weisberg@safe-biopharma.org
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here